SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,480 | +1.6% | 2,363 | -4.1% | 0.00% | – |
| Q2 2023 | $282,098 | -88.2% | 2,463 | -86.7% | 0.00% | -100.0% |
| Q1 2023 | $2,391,776 | +465.6% | 18,463 | +465.8% | 0.00% | +300.0% |
| Q4 2022 | $422,858 | -83.1% | 3,263 | -85.7% | 0.00% | -75.0% |
| Q3 2022 | $2,508,000 | -60.3% | 22,874 | -72.1% | 0.00% | -60.0% |
| Q2 2022 | $6,318,000 | -79.6% | 81,974 | -79.3% | 0.01% | -75.6% |
| Q1 2022 | $30,942,000 | +1264.3% | 396,074 | +1473.5% | 0.04% | +1266.7% |
| Q4 2021 | $2,268,000 | +959.8% | 25,172 | +918.3% | 0.00% | – |
| Q3 2021 | $214,000 | +3.4% | 2,472 | -7.5% | 0.00% | – |
| Q2 2021 | $207,000 | +2.5% | 2,672 | -1.6% | 0.00% | – |
| Q1 2021 | $202,000 | -97.5% | 2,716 | -94.3% | 0.00% | -100.0% |
| Q4 2020 | $8,166,000 | +45.5% | 47,897 | +19.8% | 0.01% | +40.0% |
| Q3 2020 | $5,613,000 | -6.3% | 39,973 | +7.0% | 0.01% | -9.1% |
| Q2 2020 | $5,988,000 | +29.1% | 37,344 | -21.2% | 0.01% | +10.0% |
| Q1 2020 | $4,638,000 | -25.2% | 47,411 | -1.3% | 0.01% | +11.1% |
| Q4 2019 | $6,197,000 | +129.6% | 48,022 | +33.6% | 0.01% | +125.0% |
| Q3 2019 | $2,699,000 | +353.6% | 35,957 | +818.4% | 0.00% | +300.0% |
| Q2 2019 | $595,000 | -82.1% | 3,915 | -86.0% | 0.00% | -83.3% |
| Q1 2019 | $3,331,000 | +714.4% | 27,948 | +644.5% | 0.01% | +500.0% |
| Q4 2018 | $409,000 | -31.0% | 3,754 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $593,000 | +25.9% | 3,670 | +3.1% | 0.00% | 0.0% |
| Q2 2018 | $471,000 | -88.1% | 3,560 | -93.3% | 0.00% | -83.3% |
| Q1 2018 | $3,942,000 | +1139.6% | 53,215 | +831.1% | 0.01% | – |
| Q4 2017 | $318,000 | +19.5% | 5,715 | -2.4% | 0.00% | – |
| Q3 2017 | $266,000 | -32.3% | 5,855 | -8.4% | 0.00% | -100.0% |
| Q3 2016 | $393,000 | +73.9% | 6,390 | -15.9% | 0.00% | – |
| Q2 2014 | $226,000 | – | 7,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |